HCPLive Network

One-Third of Female Marathon Runners Report Breast Pain

FRIDAY, April 26 (HealthDay News) -- Approximately one-third of female marathon runners report mastalgia, according to a study published online April 19 in the British Journal of Sports Medicine.

Nicola Brown, PhD, from St. Mary's University College, in London, and colleagues conducted a four-part, 30-question survey of 1,285 female marathon runners at the 2012 London Marathon Registration.

The researchers found that 32 percent of participants experienced mastalgia, which was significantly related to cup size. Mastalgia was greater during vigorous compared with moderate physical activity. Mastalgia affected exercise behavior in 17 percent of symptomatic participants. Pain medication and firm breast support were reported to be used to overcome mastalgia. No measures to relieve "discomforting" symptoms were taken by 44 percent of participants.

"This study identified that exercise was the most prevalent factor in mastalgia occurrence which may have implications for its management," the authors write.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2013 HealthDay. All rights reserved.

Further Reading
Study results show that eluxadoline may be useful in patients with diarrhea-predominant irritable bowel syndrome (IBS-D) who do not achieve symptom relief with loperamide.
Study results show significant regional variations in the types of procedures and tests administered and the number of prescriptions written for patients with irritable bowel syndrome (IBS), as well as in the number of emergency department visits and hospital admissions.
John Saltzman, MD, Discusses the gastrointestinal tract and its part in the functioning of the body.
Type 2 diabetes occurs at roughly the same prevalence in men and women. Despite the similar prevalence in the sexes, women who develop diabetes feel the effect of its complications disproportionately.
Research presented at the European League Against Rheumatism’s Annual Meeting indicates comorbid diabetes may be linked to increased osteoarthritis pain.
Analysis of a dozen phase III trials indicates that patients with atrial fibrillation face significantly less risk of major, fatal, and intracranial bleeding if they take target-specific oral anticoagulants rather than vitamin K antagonists.
Calculation and interpretation of the anion gap is extremely useful in the evaluation and treatment of the patient with metabolic acidosis. In this installment, we look at case examples involving patients with multiple sclerosis and urosepsis; COPD, diabetes, and renal failure; and type 1 diabetes.
More Reading